UK Watchdog Claims Concordia Overcharged for Thyroid Meds

International Pharmaceutical Regulatory Monitor
A A
The UK’s competition watchdog agency claimed the drugmaker Concordia overcharged the NHS by millions for its hypothyroid medication liothyronine, also known as Cytomel, following price increases of almost 6,000 percent over a decade.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor